G3BP1 and hepatocellular carcinoma: Resveratrol [160], or epigallocatechin-gallate (EGCG) [161] were, for example, reported to reduce G3BP1 expression in lung (H1299 and CL13) cancer cells [162,163], while attenuating NAFLD [164] and restraining HCC development [165].